But that's not so. Indirect costs include lab space, data storage, regulatory compliance and administrative support. The ...

The breakthrough in drug delivery hinges on the development of nanoarchaeosomes, which are nanoparticles loaded with ...

Worrying drug shortage continues for people with pancreatic cancer, charity says - Pancreatic enzyme replacement therapy ...

IIT Madras has developed a patented drug delivery system targeting breast cancer cells with nanomaterials, reducing side ...

Breast cancer (BC) is the most common malignancy among females worldwide. Breast cancer is a highly heterogeneous malignant tumor which is constitutive of ...

Developing effective treatments and understanding how the mechanism of the immune system have always been challenging for scientists. T cells, which are the frontline warriors in the battle against ...

Blood clots form in response to signals from the lungs of cancer patients -- not from other organ sites, as previously thought -- according to a preclinical study. Clots are the second-leading cause ...

One of the pillars of modern medicine is the life-saving drugs that pharmaceutical companies spend years developing to cure ...

So far in 2025, the year’s biggest cultural events have served as launchpads for several of the industry's latest cancer ...

Data on enfortumab vedotin plus pembrolizumab for advanced bladder cancer, along with updates on antibody-drug conjugates, biomarkers, and other cancer treatments, will be highlighted at the American ...

The heart drug digoxin could potentially be combined with existing cancer therapies to prevent the spread of tumors, an early ...